Source: Benzinga

Trilink Biotech: Capricor's CEO Dr. Linda Marbn to Serve as Keynote Speaker at TriLink Annual mRNA Day

SAN DIEGO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) ("Capricor" or "the Company"), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, today announced that Dr. Linda Marbán, CEO of Capricor, has accepted an invitation to serve as the keynote speaker at the TriLink Biotechnologies Annual mRNA Day Conference, taking place virtually on November 16, 2021. The global event, in partnership with Genetic Engineering News (GEN) and The CRISPR Journal, will provide a broad platform to discuss mRNA-based vaccines and therapeutics across various disease areas. As a distinguished opinion leader, Dr. Marbán will discuss the development of mRNA therapeutics and the emergence of new delivery platforms, including exosomes. "Given the emergence of mRNA technology in the fight against COVID-19, now, more than ever, there is a need for both the medical community and the general public to better understand the promise mRNA holds in combatting diseases," said Dr. Linda Marbán, CEO, Capricor Therapeutics. "As we embark on this new era of vaccinology, Capricor looks forward to working alongside other biopharma trailblazers such as TriLink to turn the tide in how we approach drug development." In November of 2019, the City and County of San Diego officially proclaimed "mRNA Day" to honor ...Full story available on

Read full article »
Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100

Trilink Biotech's headquarters is located in San Diego, California.